Prothena Corp Public (PRTA) Operating Expenses (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Operating Expenses came in at $21.0 million in Q1 2026, down 69.23% year-on-year from $68.4 million in Q1 2025, and down 13.11% quarter-over-quarter from $24.2 million in Q4 2025.
Prothena Corp Public (PRTA) Operating Expenses (2012 - 2026) Analysis & Trends
Prothena Corp Public's Operating Expenses history runs 15 years deep, the most recent figure standing at $21.0 million for Q1 2026.
- On a quarterly basis, Operating Expenses fell 69.23% year-over-year to $21.0 million in Q1 2026; TTM through Mar 2026 was $177.0 million, a 36.01% decrease from a year earlier, with the FY2025 full-year figure at $224.3 million, down 22.57% from the prior year.
- Operating Expenses eased to $21.0 million in Q1 2026 per PRTA's latest filing, from $24.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $89.0 million in Q2 2025 and bottomed at $21.0 million in Q1 2026.
- The 5-year median for Operating Expenses is $67.0 million (2024), against an average of $59.0 million.
- Across the five-year window, Operating Expenses surged 73.14% in 2022 and sank 69.23% in 2026, its largest moves.
- Year by year, Operating Expenses stood at $50.0 million in 2022, then surged by 57.68% to $78.8 million in 2023, then dropped by 14.98% to $67.0 million in 2024, then plunged by 63.86% to $24.2 million in 2025, then dropped by 13.11% to $21.0 million in 2026.
- Per Business Quant, the three latest PRTA Operating Expenses figures stand at $21.0 million (Q1 2026), $24.2 million (Q4 2025), and $42.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 21.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.05 Mn |
| Dec 31, 2025 | 24.22 Mn |
| Sep 30, 2025 | 42.66 Mn |
| Jun 30, 2025 | 89.04 Mn |
| Mar 31, 2025 | 68.41 Mn |
| Dec 31, 2024 | 67.02 Mn |
| Sep 30, 2024 | 67.48 Mn |
| Jun 30, 2024 | 73.64 Mn |
| Mar 31, 2024 | 81.58 Mn |
| Dec 31, 2023 | 78.83 Mn |
| Sep 30, 2023 | 74.56 Mn |
| Jun 30, 2023 | 70.52 Mn |
| Mar 31, 2023 | 58.49 Mn |
| Dec 31, 2022 | 50.00 Mn |
| Sep 30, 2022 | 51.85 Mn |
| Jun 30, 2022 | 44.52 Mn |
| Mar 31, 2022 | 39.10 Mn |
| Dec 31, 2021 | 34.26 Mn |
| Sep 30, 2021 | 29.95 Mn |
| Jun 30, 2021 | 32.12 Mn |